Frontotemporal dementia therapy(CAMP4 Therapeutics)

N/A

Report date: 2022/12/16 17:04:25

Base Information

Drug NameFrontotemporal dementia therapy(CAMP4 Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionProgranulin modulators
TargetsProgranulin
Therapy Area/IndicationsFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCamp4 Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesCamp4 Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A